Abstract:Objective To identify the protective effect in rat myocardial mitochondria with simvastatin following myocardial ischemia and reperfusion injury by comparative proteomics.Methods Sprague-Dawley rats were randomized to receive either simvastatin(n=14)or saline(n=14)before myocardial ischemia and reperfusion.After reperfusion,six rats from each group were used to calculate the infarction ratio by Evans blue and triphenyltetrazolium chloride(TTC)staining.Total proteins extracted from the mitochondria were applied to the two-dimensional gel electrophoresis.The differentially expressed protein spots were evaluated by a software.Then they were subjected to in-gel digestion,and analyzed by thematrix-assisted laser desorptionionization time-of-flightmass spectrometry(MALDI-TOF-MS).Results The ratio of the infarct size and the risk area(ischemia area + infarct area)was 29.4%±8.4% in the simvastatin group and 57.7%±6.5% in controls(P 0.0001).The ratio of the infarct size and the left ventricular myocardia was 15.9%±5.6% in the simvastatin group and 29.0%±8.9% in controls(P=0.012).Nineteen differentially expressed protein spots were observed,and nine of them were analyzed by MALDI-TOF-MS.Four proteins including trifunctional enzyme subunit alpha(mitochondrial precursor),electron-transferring-flavoprotein dehydrogenase,actin alpha(cardiac muscle 1)and cytochrome c oxidase subunit 5A(mitochondrial precursor)were up-regulated and five proteins including L-lactate dehydrogenase B chain,isocitrate dehydrogenase [NAD] subunit alpha(mitochondrial precursor),alpha crystallin B chain,inner membrane protein(mitochondrial)and similar to actin(cytoplasmic 2)exhibited down-regulation in the simvastatin group compared to the controls.Conclusions The infarct size of the myocardium in the simvastatin group was significantly reduced as compared to the controls.Several mitochondrial proteins concerning respiratory chain and energy metabolism in the simvastatin group were identified by proteomic analysis,which may probably illuminate the protective mechanism of simvastatin during ischemia and reperfusion injury.

Proteomics of Ischemia and Reperfusion Myocardial Mitochondria by Administration of Simvastatin